Top Stories

Qualcomm Inc. (QCOM) said Monday that a Chinese court has granted the chipmaker's request for preliminary injunction against Apple Inc. (AAPL) in China, after finding that the tech giant has infringed on two patents held by Qualcomm. Qualcomm noted...


The Reserve Bank of India Governor Urjit Patel resigned on Monday, citing personal reasons, and his decision comes after the central bank was embroiled in a series of conflicts with the Narendra Modi government over crucial matters including central bank...


With court filings by federal prosecutors about "hush money" payments to two women stirring up talk of impeachment, President Donald Trump has sought to place any blame on his former personal attorney Michael Cohen.


Stocks have climbed off their worst levels of the day but remain mostly lower in mid-day trading on Monday. The sell-off seen earlier in the day dragged the Dow and the S&P 500 down to their lowest intraday levels in seven and eight months, respectively. Currently,...


Kevin Hart, who was selected to host the next Academy Awards ceremony, has relieved himself from the role following a controversy over some homophobic tweets he made years ago. The American comedian, actor and producer made the announcement Friday...

wallstreet-oct01_03dec18.jpg After moving sharply higher at the open, stocks gave back some ground but managed to remain firmly positive throughout the trading session on Monday. With the advance on the day, the major averages added to the substantial gains posted last week.
bank-of-korea-040915.jpg South Korea's gross domestic product advanced a seasonally adjusted 0.6 percent on quarter in the third quarter of 2018, the Bank of Korea said in Tuesday's preliminary reading. That was in line with expectation and unchanged from the three months prior.
pharma-020918_03dec18.jpg The following are some of today's top gainers in the pharma/biotech sector.
pharma-022817_03dec18.jpg The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.
Read More
trump-fort-drum-121018.jpg Despite recently calling this year's $716 billion defense budget "crazy," President Donald Trump reportedly plans to ask for a sharp increase in military spending next fiscal year.
Read More
us-capitol-120618.jpg With a potential government shutdown looming, members of Congress voted Thursday to approve a short-term spending bill amid an ongoing disagreement over funding for President Donald Trump's proposed border wall. The two-week spending bill extends funding for several government agencies.
Read More
Shares of Aphria Inc. tumbled more than 23 percent in Tuesday's regular trading on the New York Stock Exchange after a short seller called the Canada-based medical cannabis company a "black hole" and alleged that the company's recent Latin American acquisitions appeared to be largely worthless. In response to the allegations, Aphria said it believes the short-seller report is malicious.
Read More
The European markets ended the first day of the new trading week in the red. Following the losses from the previous week, traders remain in a cautious mood. Concerns over the trade dispute between the U.S. and China remain and there were some major Brexit related developments to contend with as well. The...
Shares of Intec Pharma Ltd. (NTEC) touched a new 52-week high of $8.08 on Thursday, before closing the day's trading at $7.84, a gain of 110% in 3 months. The stock was trading around $3.85 when we alerted our premium subscribers to it on September 10, 2018. (Report titled "Is this stock on your radar?").
Read More
Venezuela's President Nicolás Maduro announced that his government plans to sell the oil produced in the OPEC member state in Petro from March next year to reduce dependence on the U.S. dollar. Venezuela's state-run media network TeleSUR quoted Maduro as saying that the measure is aimed at diversifying the international market, including the crypto-active forms of payment within the economic ag Read More
With already 51 new molecular entities, or NMEs, getting greenlighted by the FDA so far this year, and still 1 more month to go, 2018 could be a banner year. This outpaces the 53 new drugs approved in 1996 - the highest ever. Read More
The following are some of the pharma/biotech stocks that posted the biggest percentage decline today. Read More
Technology is a double-edged sword, and it is even truer in the case of gene editing, a revolutionary technique that involves inserting, replacing or removing DNA of a human embryo.In this week's "Did you know" column, we bring you news about the world's first gene-edited babies, the top influential films and directors, and the association between cannabis abstinence and memory improvement. Read More
ibmadnoc-dec10.jpg The Abu Dhabi National Oil Co. or ADNOC joined with IBM to pilot a blockchain-based system to integrate oil and gas production operations. The platform would track, validate and execute transactions at every stage, from the production well to the end customer. ADNOC expects the blockchain technology to reduce transaction time between its operating companies.
Read More
Follow RTT
Economic Calendar
12/10/18 9:0Trade BalanceOCT F Mexico
12/10/18 9:0ImportsOCT F Mexico
12/10/18 9:0ExportsOCT F Mexico
12/10/18 8:30Building Permits (Y-o-Y)OCT Canada
12/10/18 8:30Building Permits (M-o-M)OCT Canada
12/10/18 8:15Housing Starts (M-o-M)OCT Canada
View All
FDA Calendar
Event DateSymbolDrug NameEvent Name
02/25/19BHC, BHC.TO Loteprednol etabonate ophthalmic gel (NDA)FDA decision on Loteprednol etabonate ophthalmic gel for post-operative inflammation and pain following ocular surgery
02/18/19ALXNALXN1210 (BLA)FDA decision on ALXN1210 for the treatment of patients with paroxysmal nocturnal hemoglobinuria
02/13/19MTFBIclaprim (NDA)FDA decision on Iclaprim for acute bacterial skin and skin structure infections
02/02/19EOLSDWP-450(Resubmitted BLA)FDA decision on DWP-450 for treatment of moderate to severe glabellar lines
01/31/19ALKSALKS 5461 (NDA)FDA’s final decision on ALKS 5461 for adjunctive treatment of major depressive disorder
View All